- Home
- GILD vs HOOD Comparison
GILD vs HOOD Comparison
Compare GILD & HOOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- HOOD
- Stock Information
- Founded
- GILD 1987
- HOOD 2013
- Country
- GILD United States
- HOOD United States
- Employees
- GILD N/A
- HOOD N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- HOOD Computer Software: Prepackaged Software
- Sector
- GILD Health Care
- HOOD Technology
- Exchange
- GILD Nasdaq
- HOOD Nasdaq
- Market Cap
- GILD 145.4B
- HOOD 127.2B
- IPO Year
- GILD 1992
- HOOD 2021
- Fundamental
- Price
- GILD $122.58
- HOOD $142.48
- Analyst Decision
- GILD Buy
- HOOD Buy
- Analyst Count
- GILD 22
- HOOD 23
- Target Price
- GILD $120.90
- HOOD $112.43
- AVG Volume (30 Days)
- GILD 6.9M
- HOOD 25.2M
- Earning Date
- GILD 10-30-2025
- HOOD 11-05-2025
- Dividend Yield
- GILD 2.58%
- HOOD N/A
- EPS Growth
- GILD 6514.05
- HOOD 513.62
- EPS
- GILD 6.42
- HOOD 1.96
- Revenue
- GILD $29,087,000,000.00
- HOOD $3,567,000,000.00
- Revenue This Year
- GILD $3.05
- HOOD $46.90
- Revenue Next Year
- GILD $3.29
- HOOD $20.90
- P/E Ratio
- GILD $19.09
- HOOD $72.51
- Revenue Growth
- GILD 2.79
- HOOD 59.38
- 52 Week Low
- GILD $86.08
- HOOD $24.42
- 52 Week High
- GILD $124.61
- HOOD $153.86
- Technical
- Relative Strength Index (RSI)
- GILD 61.86
- HOOD 54.34
- Support Level
- GILD $114.02
- HOOD $137.25
- Resistance Level
- GILD $121.58
- HOOD $150.46
- Average True Range (ATR)
- GILD 3.17
- HOOD 6.61
- MACD
- GILD 0.07
- HOOD -0.44
- Stochastic Oscillator
- GILD 80.83
- HOOD 73.02
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About HOOD Robinhood Markets Inc.
Robinhood Markets Inc is creating a modern financial services platform. It designs its own products and services and delivers them through a single, app-based cloud platform supported by proprietary technology. Its vertically integrated platform has enabled the introduction of new products and services such as cryptocurrency trading, dividend reinvestment, fraud detection, derivatives, fractional shares, recurring investments, and others.